Moreover, abnormal activation of the Wnt/β-catenin and AKT/mTOR pathways is frequently observed in various cancers, including colorectal cancer; therefore, the components of these pathways constitute attractive therapeutic targets (Cheng et al., 2019; Yang et al., 2019). Here, MTOR is linked to cancer.